Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST StudyHolger Eidtmann, Robert E. Coleman, Richard de Boer et al.|Annals of Oncology|2010Cited by 280
The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven CancersMeagan B. Ryan, Margit Hagel, Bradley Quade et al.|Cancer Discovery|2024Cited by 43
Supplementary Methods from The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven CancersMeagan B. Ryan, Margit Hagel, Bradley Quade et al.|Unknown|2024Cited by 1
Data from The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven CancersMeagan B. Ryan, Margit Hagel, Bradley Quade et al.|Unknown|2024Cited by 1
Supplementary Table 8 from The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven CancersMeagan B. Ryan, Margit Hagel, Bradley Quade et al.|Unknown|2024Cited by 0